SRT Therapeutics Inc. Company Profile, Contacts & Intelligence

SRT Therapeutics Inc. Overview

SRT Therapeutics is a San Diego-based biotech company established in 2024 by the founders of Prometheus Biosciences, Steph Targan, MD (Cedars Sinai), Janine Bilsborough, Ph.D. (Cedars Sinai), the scientific team that discovered Tulisokibart (MK7240) and the role of TL1A in IBD and Scott Glenn and Lauren Otsuki, the drug development team that took Tulisokibart (MK7240) from academia into the clinic. Building on the demonstrated success of the precision medicine approach in IBD with Tulisokibart, SRT Therapeutics will expand this approach by targeting key pathways that not only modulate inflammatory pathways, but also promote tissue healing in IBD. This strategy will move SRT Therapeutics beyond the current empirical treatment model to realize the goal of enhancing both outcomes and the quality of care for our patients.

Headquarters

San Diego, California, United States

Website

srt-tx.com

Industry

Biotechnology Research

Founded

2024

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

SRT Therapeutics Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

SRT Therapeutics Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

SRT Therapeutics Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

SRT Therapeutics Inc. Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to SRT Therapeutics Inc.

Explore companies in related markets and compare their industry and employee estimates.